India's COVID-19 response showcased proactive leadership, timely decisions, and adaptive governance, from early screening to massive vaccination, managing an unprecedented public health crisis.
India's COVID-19 response, from January 2020 to May 2023, unfolded through five phases of preparedness, containment, and adaptation.
The World Health Organization (WHO) withdrew the Public Health Emergency of International Concern on May 5, 2023.
As of December 31, 2025, 97% of the population aged 12 years and above received at least one COVID-19 vaccine dose, with 90% fully vaccinated.
Early actions included Joint Monitoring Group meetings, airport screening, and invoking the Disaster Management Act, 2005 and Epidemic Diseases Act, 1897.
Empowered Groups were constituted to manage various aspects of the response, evolving in structure as needs changed.
The ECRP-II (India COVID-19 Emergency Response and Health System Preparedness Package Phase II) was approved with an outlay of ₹23,123 crore.
Key initiatives included the Aarogya Setu app, INSACOG for genomic surveillance, and the Har Ghar Dastak vaccination campaign.
Detailed Insights:
India's response was characterized by timely decisions, clear mandates, constant course correction, and evidence-guided actions.
Anticipation involved screening international passengers from January 2020, preceding India's first reported case in Thrissur, Kerala.
The government delegated legal powers, established a national operations centre, and evacuated citizens from Wuhan.
Adaptability was demonstrated by reshaping the command structure, including the evolution of Empowered Groups and local zoning (red, orange, green).
Decisions were guided by data from national serosurveys and genomic sequencing, leading to phased reopening strategies.
Enablement involved bringing in private laboratories, industry for Personal Protective Equipment (PPE) production, and leveraging schemes like PMJAY and CGHS for hospital beds.
Leadership was present at all levels, from Prime Minister-chaired reviews to multidisciplinary Central teams deputed to States.
Decisive actions during the second wave included mapping and allocating oxygen to states and liberalizing vaccine procurement and production.
The vaccination drive expanded progressively, starting with health workers and eventually covering all adults and adolescents, including precaution doses.
ECRP-II focused on strengthening district and sub-district health capacity through the National Health Mission, providing new laboratories and oxygen infrastructure.
India's Accredited Social Health Activists (ASHAs) received the WHO Director-General's Global Health Leaders Award in May 2022 for their contributions.
Key Concepts Involved:
Joint Monitoring Group (JMG): A standing technical forum of health officials and experts for risk assessment and readiness review.
Empowered Groups: Committees of senior officials constituted to manage specific areas of the COVID-19 response, such as medical plans, testing, and supply chains.
Serosurvey: A test of blood samples from a population cross-section to estimate the proportion already infected by detecting antibodies.
INSACOG (Indian SARS-CoV-2 Consortium on Genomics): A genomic surveillance network established to monitor genomic variations of the SARS-CoV-2 virus.
ECRP-II (India COVID-19 Emergency Response and Health System Preparedness Package Phase II): A government package aimed at strengthening district and sub-district health infrastructure and capacity.
Har Ghar Dastak: A nationwide house-to-house vaccination campaign launched to ensure awareness, mobilization, and vaccination of eligible beneficiaries.